Treatment of HF-fed mice with a SOD mimetic or MitoQ, or genetic overexpression of catalase within mitochondria, not only lowered mitochondrial oxidants, hyperpolarization, Ca2+ levels, and platelet activation but also protected against increased potential for carotid and pulmonary thrombosis. This evidence concerns the gene CAT and deep vein thrombosis.